Printer Friendly

QMED REPORTS A 46 PERCENT INCREASE IN NET SALES IN THE THIRD QUARTER

 QMED REPORTS A 46 PERCENT INCREASE IN NET SALES IN THE THIRD QUARTER
 LAURENCE HARBOR, N.J., Sept. 28 /PRNewswire/ -- qmed, Inc. (NASDAQ: QEKG), reported today the company's net sales for the third quarter ending Aug. 31, 1992 had risen 46 percent to $2,818,179 vs. $1,930,221 in the corresponding period last year. qmed also reported a 23 percent rise in net revenues to $6,790,106 vs. $5,529,781 for the nine months ending Aug. 31, 1992.
 Michael W. Cox, CEO of qmed, commented that "sales of our new products, VasoSpect and Interp-1000, are selling faster than we anticipated, accounting for approximately 33 percent of revenues." Mr. Cox also said that "Monitor One sales continue at a strong double digit growth, thanks in part to a favorable medical article on Monitor One's ability to detect 'silent heart disease,' which appeared in the June issue of the Journal of the American College of Cardiology."
 qmed, INC.
 Periods ended Nine Months Three Months
 Aug. 31 1992 1991 1992 1991
 Net sales $6,790,106 $5,529,781 $2,818,179 $1,930,221
 Gross profit 5,259,280 4,246,700 2,145,029 1,462,293
 SG&A 4,981,875 3,796,395 1,967,054 1,333,376
 Provision for
 uncollectable
 accounts 9,113 68,832 -- --
 R&D 414,762 276,375 153,455 90,600
 Income (loss) from
 operations (146,470) 105,098 24,520 38,317
 Interest expense 101,428 214,174 25,921 65,084
 Other income 44,886 149,356 15,492 34,604
 Net income (loss) $ (203,012) $ 40,280 $ 14,091 $ 7,837
 Income (loss) per share $(.03) $.01 $.00 $.00
 Average shares 7,245,592 6,640,315 7,659,038 6,640,315
 -0- 9/28/92
 /CONTACT: Michael W. Cox, president and CEO of qmed, 800-237-2039, or fax, 908-566-0912/
 (QEKG) CO: qmed, Inc. ST: New Jersey IN: HEA SU: ERN


GK-TS -- NY007 -- 3813 09/28/92 08:16 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Sep 28, 1992
Words:334
Previous Article:APPLE REDUCES SUGGESTED RETAIL PRICES ON MANY MACINTOSH PRODUCTS IN THE U.S.
Next Article:APPLE USA SIGNS MERISEL AND TECH DATA FOR SOFTWARE DISTRIBUTION
Topics:


Related Articles
QUEST MEDICAL INC. PRE-TAX OPERATING EARNINGS RISE TO $424,000 FOR THE FOURTH QUARTER FROM $17,000 LAST YEAR AS REVENUE INCREASES 81 PERCENT
QUEST MEDICAL, INC. (NASDAQ) SECOND QUARTER OPERATING EARNINGS ADVANCE 78 PERCENT ON 43 PERCENT REVENUE GAIN
STRYKER PROFITS UP 47 PERCENT FOR QUARTER ENDED SEPT. 30, 1992
QUEST MEDICAL INC. REPORTS FOURTH QUARTER, 1992 RESULTS
QMED REPORTS A 3.3 PERCENT RISE IN FIRST QUARTER SALES
qmed REPORTS A 36 PERCENT INCREASE IN SECOND QUARTER SALES
QMED REPORTS PROFITABLE THIRD QUARTER
QMED REPORTS A 41% REDUCTION IN FIRST QUARTER LOSS, COMPARED TO PRIOR YEAR
QMED REPORTS THIRD QUARTER RESULTS
qmed Reports Second Quarter Results

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters